Fortress Biotech, Inc. (FBIOP) Finished Goods (2020 - 2025)
Fortress Biotech (FBIOP) posted quarterly Finished Goods of $10.0 million for Q1 2025, up 70.95% year-over-year from $5.9 million in Q1 2024, and down 11.91% quarter-over-quarter from $11.4 million in Q4 2024.
Fortress Biotech, Inc. (FBIOP) Finished Goods (2020 - 2025) Analysis & Trends
Fortress Biotech's Finished Goods history runs 6 years deep, the most recent figure standing at $10.0 million for Q1 2025.
- In Q1 2025, Finished Goods rose 70.95% year-over-year to $10.0 million; the TTM figure through Mar 2025 stood at $10.0 million (up 70.95% YoY), while the FY2024 annual figure was $11.4 million, up 128.21% from the prior year.
- Finished Goods for Q1 2025 stood at $10.0 million, down from $11.4 million in the prior quarter.
- The five-year high for Finished Goods was $11.4 million in Q4 2024, with the low at $4.3 million in Q4 2021.
- The 5-year median for Finished Goods is $7.1 million (2023), against an average of $7.3 million.
- The sharpest annual moves came in 2021 and 2023: Finished Goods surged 205.56% in 2021, then slumped 35.56% in 2023.
- Fortress Biotech's Finished Goods stood at $4.3 million in 2021, then soared by 80.4% to $7.7 million in 2022, then slumped by 35.56% to $5.0 million in 2023, then soared by 128.21% to $11.4 million in 2024, then slipped by 11.91% to $10.0 million in 2025.
- Business Quant data shows FBIOP's Finished Goods at $10.0 million in Q1 2025, $11.4 million in Q4 2024, and $8.7 million in Q3 2024.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 10.03 Mn |
| Dec 31, 2024 | 11.38 Mn |
| Sep 30, 2024 | 8.72 Mn |
| Jun 30, 2024 | 6.21 Mn |
| Mar 31, 2024 | 5.87 Mn |
| Dec 31, 2023 | 4.99 Mn |
| Sep 30, 2023 | 6.68 Mn |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 7.26 Mn |
| Dec 31, 2022 | 7.74 Mn |
| Sep 30, 2022 | 8.15 Mn |
| Jun 30, 2022 | 6.24 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 6.16 Mn |
| Jun 30, 2021 | 9.41 Mn |
| Dec 31, 2020 | 1.40 Mn |